Observational studyMultiple sclerosis (Houndmills, Basingstoke, England)2023

Vaccine-breakthrough SARS-CoV-2 infections in people with multiple sclerosis and related conditions: An observational study by the New York COVID-19 Neuro-Immunology Consortium (NYCNIC-2).

Sylvia Klineova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.